Roda, Presco S.
HRN: 26-23-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/15/2024
11/22/2024
IVT
500mg
Q8
Hepatic Encephalopathy
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous SystemDisseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes